An in vitro förster resonance energy transfer-based high-throughput screening assay for inhibitors of protein-protein interactions in SUMOylation pathway

Assay and Drug Development Technologies

Volumn 10, Issue 4, 2012, Pages 336-343

  Song, Yang ^a   Liao, Jiayu ^a,b  

^a University of California ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; PROTEIN UBC9; SUMO 1 PROTEIN;

ARTICLE; BACTERIAL CELL; CONTROLLED STUDY; ESCHERICHIA COLI; FLUORESCENCE RESONANCE ENERGY TRANSFER; HIGH THROUGHPUT SCREENING; NONHUMAN; PILOT STUDY; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; STEADY STATE; SUMOYLATION;

ALGORITHMS; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; FLUORESCENCE RESONANCE ENERGY TRANSFER; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; POLYMERASE CHAIN REACTION; RECOMBINANT FUSION PROTEINS; REPRODUCIBILITY OF RESULTS; SIGNAL-TO-NOISE RATIO; SUMO-1 PROTEIN; SUMOYLATION; UBIQUITIN-CONJUGATING ENZYMES; UREA;

EID: 84865493167     PISSN: 1540658X     EISSN: 15578127     Source Type: Journal    
DOI: 10.1089/adt.2011.0394     Document Type: Article

References (37)

1. Peterson CL, Laniel MA: Histones and histone modifications. Curr Biol 2004;14:R546-R551.
2. Yang XJ: Multisite protein modification and intramolecular signaling. Oncogene 2005;24:1653-1662.
3. Pandita TK, Richardson C: Chromatin remodeling finds its place in the DNA double-strand break response. Nucleic Acids Res 2009;37:1363-1377.
4. Gill G: SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Genes Dev 2004;18:2046-2059. (Pubitemid 39166622)
5. Muller S, Hoege C, Pyrowolakis G, Jentsch S: SUMO, ubiquitin's mysterious cousin. Nat Rev Mol Cell Biol 2001;2:202-210. (Pubitemid 33675745)
6. Yeh ET, Gong L, Kamitani T: Ubiquitin-like proteins: new wines in new bottles. Gene 2000;248:1-14. (Pubitemid 30259196)
7. Bayer P, Arndt A, Metzger S, et al.: Structure determination of the small ubiquitin-related modifier SUMO-1. J Mol Biol 1998;280:275-286. (Pubitemid 28325519)
8. Johnson ES: Protein modification by SUMO. Annu Rev Biochem 2004;73:355-382. (Pubitemid 39050373)
9. Desterro JM, Rodriguez MS, Hay RT: SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell 1998;2:233-239. (Pubitemid 128373648)
10. Alarcon-Vargas D, Ronai Z: SUMO in cancer-wrestlers wanted. Cancer Biol Ther 2002;1:237-242.
11. Steffan JS, Agrawal N, Pallos J, et al.: SUMO modification of Huntingtin and Huntington's disease pathology. Science 2004;304:100-104. (Pubitemid 38451465)
12. Liu B, Mink S, Wong KA, et al.: PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity. Nat Immunol 2004;5:891-898. (Pubitemid 39276233)
13. Yeh ET: SUMOylation and De-SUMOylation: wrestling with life's processes. J Biol Chem 2009;284:8223-8227.
14. Gong L, Li B, Millas S, Yeh ET: Molecular cloning and characterization of human AOS1 and UBA2, components of the sentrin-activating enzyme complex. FEBS Lett 1999;448:185-189. (Pubitemid 29151657)
15. Johnson ES, Schwienhorst I, Dohmen RJ, Blobel G: The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer. EMBO J 1997;16:5509-5519. (Pubitemid 27399843)
16. Olsen SK, Capili AD, Lu X, Tan DS, Lima CD: Active site remodelling accompanies thioester bond formation in the SUMO E1. Nature 2010;463:906-912.
17. Huang DT, Hunt HW, Zhuang M, Ohi MD, Holton JM, Schulman BA: Basis for a ubiquitin-like protein thioester switch toggling E1-E2 affinity. Nature 2007;445:394-398. (Pubitemid 46160903)
18. Yunus AA, Lima CD: Structure of the Siz/PIAS SUMO E3 ligase Siz1 and determinants required for SUMO modification of PCNA. Mol Cell 2009;35:669-682.
19. Tang Z, Hecker CM, Scheschonka A, Betz H: Protein interactions in the sumoylation cascade: lessons from X-ray structures. FEBS J 2008;275:3003-3015. (Pubitemid 351743581)
20. Elrouby N, Coupland G: Proteome-wide screens for small ubiquitin-like modifier (SUMO) substrates identify Arabidopsis proteins implicated in diverse biological processes. Proc Natl Acad Sci USA 2010;107:17415-17420.
21. Kroetz MB, Hochstrasser M: Identification of SUMO-interacting proteins by yeast two-hybrid analysis. Methods Mol Biol 2009;497:107-120.
22. Reverter D, Lima CD: Insights into E3 ligase activity revealed by a SUMORanGAP1-Ubc9-Nup358 complex. Nature 2005;435:687-692. (Pubitemid 40825514)
23. Knipscheer P, van Dijk WJ, Olsen JV, Mann M, Sixma TK: Noncovalent interaction between Ubc9 and SUMO promotes SUMO chain formation. EMBO J 2007;26:2797-2807. (Pubitemid 46884280)
24. Windecker H, Ulrich HD: Architecture and assembly of poly-SUMO chains on PCNA in Saccharomyces cerevisiae. J Mol Biol 2008;376:221-231.
25. Yang M, Hsu CT, Ting CY, Liu LF, Hwang J: Assembly of a polymeric chain of SUMO1 on human topoisomerase I in vitro. J Biol Chem 2006;281:8264-8274. (Pubitemid 43847447)
26. Fukuda I, Ito A, Hirai G, et al.: Ginkgolic acid inhibits protein SUMOylation by blocking formation of the E1-SUMO intermediate. Chem Biol 2009;16:133-140.
27. Fukuda I, Ito A, Uramoto M, et al.: Kerriamycin B inhibits protein SUMOylation. J Antibiot 2009;62:221-224.
28. Carlson CB, Horton RA, Vogel KW: A toolbox approach to high-throughput TRFRET-based SUMOylation and DeSUMOylation assays. Assay Drug Dev Technol 2009;7:348-355.
29. Dams G, Van Acker K, Gustin E, et al.: A time-resolved fluorescence assay to identify small-molecule inhibitors of HIV-1 fusion. J Biomol Screen 2007;12:865-874. (Pubitemid 47340705)
30. Gordon GW, Berry G, Liang XH, Levine B, Herman B: Quantitative fluorescence resonance energy transfer measurements using fluorescence microscopy. Biophys J 1998;74:2702-2713. (Pubitemid 28225264)
31. Saucerman JJ, Zhang J, Martin JC, et al.: Systems analysis of PKA-mediated phosphorylation gradients in live cardiac myocytes. Proc Natl Acad Sci USA 2006;103:12923-12928. (Pubitemid 44298662)
32. Song Y, Madahar V, Liao J: Development of FRET assay into quantitative and high-throughput screening technology platforms for protein-protein interactions. Ann Biomed Eng 2011;39:1224-1234.
33. Nguyen AW, Daugherty PS: Evolutionary optimization of fluorescent proteins for intracellular FRET. Nat Biotechnol 2005;23:355-360. (Pubitemid 41094425)
34. Zhang JH, Chung TD, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4:67-73. (Pubitemid 29278954)
35. Solly K, Cassaday J, Felix JP, et al.: Miniaturization and HTS of a FRET-based membrane potential assay for K (ir) channel inhibitors. Assay Drug Dev Technol 2008;6:225-234. (Pubitemid 351670379)
36. Wells JA, McClendon CL: Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 2007;450:1001-1009. (Pubitemid 350273630)
37. Arkin MR, Wells JA: Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov 2004;3:301-317. (Pubitemid 38499758)